Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials

Depressive Disorder ◽

Serotonin Reuptake ◽

Randomized Clinical Trials ◽

Meta Analysis ◽

Major Depressive ◽

Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: A meta-analysis of individual patient data from 10 double-blind, randomized clinical trials

Journal of Psychiatric Research ◽

10.1016/j.jpsychires.2007.05.012 ◽

2008 ◽

Vol 42 (2) ◽

pp. 134-140 ◽

Cited By ~ 19

Author(s):

George I. Papakostas ◽

Madhukar H. Trivedi ◽

Jonathan E. Alpert ◽

Cheryl A. Seifert ◽

Alok Krishen ◽

...

Keyword(s):

Clinical Trials ◽

Depressive Disorder ◽

Serotonin Reuptake ◽

Randomized Clinical Trials ◽

Individual Patient Data ◽

Meta Analysis ◽

Major Depressive ◽

Double Blind

A meta-analysis of clinical trials comparing mirtazapine with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

Journal of Psychopharmacology ◽

10.1177/0269881107083808 ◽

2008 ◽

Vol 22 (8) ◽

pp. 843-848 ◽

Cited By ~ 48

Author(s):

GI Papakostas ◽

CH Homberger ◽

M. Fava

Keyword(s):

Clinical Trials ◽

Depressive Disorder ◽

Serotonin Reuptake ◽

Meta Analysis ◽

Selective Serotonin ◽

Major Depressive

A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2007.07.005 ◽

2008 ◽

Vol 18 (2) ◽

pp. 122-127 ◽

Cited By ~ 42

Author(s):

George I. Papakostas ◽

J. Craig Nelson ◽

Siegfried Kasper ◽

Hans-Jürgen Möller

Keyword(s):

Clinical Trials ◽

Depressive Disorder ◽

Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Meta Analysis ◽

Major Depressive ◽

Norepinephrine Reuptake Inhibitor ◽

A meta-analysis of clinical trials comparing milnacipran, a serotonin–norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2006.05.001 ◽

2007 ◽

Vol 17 (1) ◽

pp. 32-36 ◽

Cited By ~ 31

Author(s):

George I. Papakostas ◽

Maurizio Fava

Keyword(s):

Clinical Trials ◽

Depressive Disorder ◽

Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Meta Analysis ◽

Major Depressive ◽

Norepinephrine Reuptake Inhibitor ◽

Serotonin Norepinephrine Reuptake Inhibitor ◽

Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder

The World Journal of Biological Psychiatry ◽

10.1080/15622970701432528 ◽

2007 ◽

pp. 1-8 ◽

Cited By ~ 2

Author(s):

George I. Papakostas ◽

Dana Charles ◽

Maurizio Fava

Keyword(s):

Depressive Disorder ◽

Serotonin Reuptake ◽

Meta Analysis ◽

Dose Finding ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors in Pediatric Major Depressive Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2015.05.004 ◽

2015 ◽

Vol 54 (7) ◽

pp. 557-564 ◽

Cited By ~ 26

Author(s):

Anjali L. Varigonda ◽

Ewgeni Jakubovski ◽

Matthew J. Taylor ◽

Nick Freemantle ◽

Catherine Coughlin ◽

...

Keyword(s):

Systematic Review ◽

Depressive Disorder ◽

Early Treatment ◽

Serotonin Reuptake ◽

Meta Analysis ◽

Major Depressive ◽

Treatment Responses

Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder

The World Journal of Biological Psychiatry ◽

10.3109/15622970701432528 ◽

2010 ◽

Vol 11 (2-2) ◽

pp. 300-307 ◽

Cited By ~ 21

Author(s):

George I. Papakostas ◽

Dana Charles ◽

Maurizio Fava

Keyword(s):

Depressive Disorder ◽

Serotonin Reuptake ◽

Meta Analysis ◽

Dose Finding ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Treatment of cognitive dysfunction in major depressive disorder—a review of the preclinical evidence for efficacy of selective serotonin reuptake inhibitors, serotonin–norepinephrine reuptake inhibitors and the multimodal-acting antidepressant vortioxetine

European Journal of Pharmacology ◽

10.1016/j.ejphar.2014.07.044 ◽

2015 ◽

Vol 753 ◽

pp. 19-31 ◽

Cited By ~ 51

Author(s):

Alan L. Pehrson ◽

Steven C. Leiser ◽

Maria Gulinello ◽

Elena Dale ◽

Yan Li ◽

...

Keyword(s):

Depressive Disorder ◽

Cognitive Dysfunction ◽

Serotonin Reuptake ◽

Selective Serotonin ◽

Major Depressive ◽

A Metaanalysis of Clinical Trials Comparing Moclobemide with Selective Serotonin Reuptake Inhibitors for the Treatment of Major Depressive Disorder

The Canadian Journal of Psychiatry ◽

10.1177/070674370605101208 ◽

2006 ◽

Vol 51 (12) ◽

pp. 783-790 ◽

Cited By ~ 35

Author(s):

George I Papakostas ◽

Maurizio Fava

Keyword(s):

Clinical Trials ◽

Depressive Disorder ◽

Serotonin Reuptake ◽

Selective Serotonin ◽

Major Depressive

The impact of selective serotonin reuptake inhibitors on the thyroid function among patients with major depressive disorder: A systematic review and meta-analysis

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2020.01.011 ◽

2020 ◽

Vol 33 ◽

pp. 139-145

Author(s):

Arthur Caye ◽

Luisa K. Pilz ◽

Ana L. Maia ◽

Maria Paz Hidalgo ◽

Toshi A. Furukawa ◽

...

Keyword(s):

Systematic Review ◽

Depressive Disorder ◽

Thyroid Function ◽

Serotonin Reuptake ◽

Meta Analysis ◽

Major Depressive ◽

The Impact